-
Commerzbank staff's legal bid against UniCredit rejected
-
China approves fast-fashion giant Shein's Hong Kong listing bid
-
Amnesty calls latest US deportation to Eswatini 'unlawful'
-
Jihadist insurgency hampers Nigeria cholera outbreak response
-
Syria says IS behind Damascus blasts, finds explosives cache
-
Foreigners among 12 dead in Spanish wildfire
-
Nasdaq dips as SK hynix arrives in NY
-
England advised to avoid alcohol after off-field dramas - report
-
Fiji captain shrugs off chairman's criticism ahead of England clash
-
Memorable moments from Paris Haute Couture Week
-
Hundreds welcome Salah's Egypt home after best World Cup run
-
Dust in the wind: intense storms struck China, US in 2025, says UN
-
Piercing, matcha rituals lead Noskova in Kvitova's footsteps
-
Finally healthy, music lover Muchova eyes Wimbledon glory
-
France wildfires burn twice as much land as last year: official
-
Muchova, Noskova put friendship on hold to fight for Wimbledon title
-
Mandhana's fifty lights up inaugural women's Test at Lord's
-
MEXC Launches VVIP Futures Loss Coverage Program 2.0 with 1,000,000 USDT Prize Pool
-
England World Cup winner Stiles died with brain injury, court told
-
Foreigners among 11 dead in Spanish wildfires
-
Stocks rise as SK hynix boosts AI trade
-
Volkswagen sales slide further as carmaker weighs mass job cuts
-
England bowl against India in historic first women's Test at Lord's
-
Gagan Gupta, man on a mission to industrialise Africa
-
Eleven dead, 19 missing as wildfire roars through southern Spain
-
Eleven dead, 19 missing as Spain wildfire roars through southern Spain
-
EU tells Meta to change Facebook, Instagram's 'addictive design'
-
Man nearly sucked out of 'detached' window on Ryanair flight
-
EasyJet accepts rival takeover bid from US investor Apollo
-
Record visitors, record taxes: Vienna cashes in on tourist boom
-
UK schools, mentors team up to rescue 'lost boys' with football
-
Landslides kill 15 in Philippines as biggest typhoon in decades nears Taiwan
-
India's choked pavements fail pedestrians
-
Jungle spirit: Myanmar fighters try to keep hope alive
-
It's coming home: Bayeux tapestry arrives in London in overnight operation
-
Beirne hails 'special moment' as he prepares to captain Ireland
-
Pacific Islands reject missile test in 'blue continent'
-
Indonesia says landfill fire near Jakarta extinguished
-
Wallabies skipper Wilson has full faith in rookie flyhalf
-
Spain aim for World Cup date with France by beating Belgium
-
Landslide kills five in Philippines as biggest typhoon in decades nears Taiwan
-
Bayeux Tapestry arrives in London after epic journey from France
-
Modi visits New Zealand as trade deal sparks India pushback
-
North Korea vows boost to nuclear buildup, military intelligence
-
Bayeux Tapestry to arrive in London after epic journey from France
-
H5 bird flu detected in Australian seabird for first time
-
Syria authorities say captured IS-linked cell behind blasts
-
Myanmar's pro-democracy revolution weakens five years on
-
Table for one: how Japan's 'Solitary Gourmet' became a TV hit
-
Hundreds flee homes in Taiwan ahead of biggest typhoon in decades
Sokolove Law Now Taking Gabapentin Cases Linked to Dementia & Cognitive Decline
National Law Firm Investigates Whether Manufacturers Hid the Risks of Gabapentin Use
BOSTON, MA / ACCESS Newswire / June 4, 2026 / Sokolove Law, one of the nation's leading personal injury and mass tort law firms, announced today that it is now accepting cases from patients who developed dementia or experienced significant cognitive decline after long-term use of gabapentin (Neurontin®).
Gabapentin is one of the most widely prescribed medications in the United States. While it is FDA-approved to treat certain types of nerve pain and seizures, it's also commonly prescribed off-label for conditions like back pain and migraines.
However, emerging research has raised serious concerns about a potential link between prolonged gabapentin use and cognitive impairment - including memory loss, confusion, and dementia.
Lawsuits allege that Pfizer, the drug's manufacturer, failed to adequately warn patients and physicians about these risks.
"Millions of Americans have been prescribed gabapentin, often for years, trusting that it was safe," said Ricky LeBlanc, Managing Attorney at Sokolove Law. "If ongoing research confirms that gabapentin can contribute to cognitive decline, patients and their families deserve clear answers about what was known, when it was known, and who should be held accountable."
Sokolove Law is currently reviewing potential cases involving individuals who took gabapentin for an extended period and subsequently received a diagnosis of dementia or Alzheimer's disease.
Affected patients and their families can receive a free, no-obligation case review to see if they may be able to take legal action. There is no cost to speak with the firm, and clients pay nothing unless compensation is secured on their behalf.
About Sokolove Law
Sokolove Law is a national personal injury law firm headquartered in Chestnut Hill, Massachusetts. Since 1979, the firm has helped people across the U.S. pursue justice and compensation in cases involving mesothelioma, birth injury, sexual abuse, nursing home neglect, and dangerous pharmaceuticals and devices, securing over $10 billion total. By helping clients nationwide, Sokolove Law aims to make the legal system accessible to everyone. Learn more at www.sokolovelaw.com.
Media Contact:
Audrey Fisher
[email protected]
SOURCE: Sokolove Law
View the original press release on ACCESS Newswire
F.Schneider--AMWN